Crumly & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Sell |
599
-380
| -39% | -$296K | 0.11% | 104 |
|
|
2025
Q1 | $809K | Buy |
979
+523
| +115% | +$432K | 0.22% | 66 |
|
|
2024
Q4 | $352K | Hold |
456
| – | – | 0.1% | 111 |
|
|
2024
Q3 | $404K | Sell |
456
-224
| -33% | -$198K | 0.11% | 111 |
|
|
2024
Q2 | $616K | Sell |
680
-177
| -21% | -$160K | 0.18% | 78 |
|
|
2024
Q1 | $667K | Buy |
+857
| New | +$667K | 0.18% | 74 |
|
|
2021
Q4 | – | Sell |
-1,101
| Closed | -$254K | – | 112 |
|
|
2021
Q3 | $254K | Buy |
1,101
+4
| +0.4% | +$923 | 0.12% | 94 |
|
|
2021
Q2 | $252K | Buy |
1,097
+4
| +0.4% | +$919 | 0.12% | 92 |
|
|
2021
Q1 | $204K | Buy |
1,093
+4
| +0.4% | +$747 | 0.12% | 92 |
|
|
2020
Q4 | $224K | Buy |
+1,089
| New | +$224K | 0.16% | 74 |
|